Chatham, NJ, United States of America

Pablo Jimenez


Average Co-Inventor Count = 10.2

ph-index = 4

Forward Citations = 80(Granted Patents)


Location History:

  • Ellicott, MD (US) (2003)
  • Ellicott City, MD (US) (2000 - 2005)
  • Ellicot City, MD (US) (2005)
  • Chatham, NJ (US) (2004 - 2010)

Company Filing History:


Years Active: 2000-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Ingenious Mind of Pablo Jimenez: Innovator in Myeloid Progenitor Research**

Introduction

Pablo Jimenez, located in Chatham, NJ, is a groundbreaking inventor recognized for his significant contributions to the field of biomedical research. With a remarkable portfolio of 10 patents, he focuses on therapeutic compositions and methodologies that revolutionize treatment options in immunology.

Latest Patents

Among his most notable inventions are the patents related to Myeloid Progenitor Inhibitory Factor-1 (MPIF-1) polypeptides. These patents disclose innovative therapeutic compositions and methods utilizing isolated nucleic acid molecules encoding MPIF-1, previously referred to as MIP-3, along with human monocyte-colony inhibitory factor (M-CIF) polypeptides and macrophage inhibitory protein-4 (MIP-4). This technology has broad implications in treating various diseases, showcasing his dedication to improving human health.

Career Highlights

Pablo Jimenez is currently employed at Human Genome Sciences, Inc., where his expertise enhances the company’s focus on genomic medicine and therapeutic innovation. His work not only pushes the boundaries of science but also embodies a commitment to translating complex research into viable medical solutions.

Collaborations

Throughout his career, Jimenez has collaborated with distinguished colleagues, including Donna Mendrick and Jun Zhang. Their collective efforts have further advanced the understanding and application of his inventions, underscoring the importance of teamwork in the scientific community.

Conclusion

Pablo Jimenez is an exemplary inventor whose work in the realm of myeloid progenitor research signifies a vital leap toward more effective medical treatments. With a robust portfolio of patents, he continues to pave the way for innovations that may have a lasting impact on the world of biomedical research. Through collaboration and dedication, Jimenez exemplifies the spirit of innovation essential for driving progress in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…